Phloretin

Phloretin is a dihydrochalcone polyphenol found predominantly in apple skin and leaves that exerts antioxidant, antibacterial, and potential anticancer effects. Its primary mechanisms involve free radical scavenging via hydroxyl groups and disruption of bacterial phospholipid membranes.

Origin & History

Phloretin is a dihydrochalcone natural phenol compound (C₁₅H₁₄O₅) found primarily in apple tree leaves, branches, and fruits, as well as pears, strawberries, and Manchurian apricots. It is extracted from plant sources like apple pomace or produced through microbial whole-cell biocatalysis to achieve >98% purity as a white to light-yellow crystalline solid.

Historical & Cultural Context

No traditional medicine use or historical context is documented in the research dossier. The compound's traditional applications remain undocumented.

Health Benefits

• Antioxidant properties - functions as a plant-defense antioxidant compound (evidence: preliminary)
• Antibacterial activity - damages bacterial cell membranes through hydroxyl group interactions with phospholipids (evidence: preliminary)
• Potential cancer cell synergy - may enhance cisplatin effects in lung cancer cell lines A549, Calu-1, H838, H520 (evidence: in vitro only)
• No human clinical benefits documented in the research dossier
• Additional benefits remain unverified due to lack of human trials

How It Works

Phloretin scavenges reactive oxygen species through its phenolic hydroxyl groups, particularly at the 2', 4', 6', and 4-positions of its chalcone backbone, inhibiting lipid peroxidation and reducing oxidative stress markers. It disrupts bacterial cell membrane integrity by interacting with phospholipid head groups via hydrogen bonding, increasing membrane permeability and causing ion leakage. In cancer research contexts, phloretin appears to inhibit glucose transporter GLUT2 and modulate cisplatin-induced apoptotic pathways, potentially enhancing cytotoxic drug uptake in tumor cells.

Scientific Research

The research dossier contains no human clinical trials, RCTs, or meta-analyses for phloretin. Only in vitro studies are mentioned, including potential synergistic effects with cisplatin in lung cancer cell lines, but no PubMed PMIDs or specific study details are provided.

Clinical Summary

Most evidence supporting phloretin's benefits comes from in vitro cell studies and rodent models rather than human clinical trials, placing overall evidence strength at preliminary. Animal studies have demonstrated antioxidant activity at doses ranging from 10–50 mg/kg, with reductions in malondialdehyde and increases in superoxide dismutase activity. In vitro antibacterial studies show minimum inhibitory concentrations against pathogens like Staphylococcus aureus and Escherichia coli in the range of 64–256 µg/mL, though translation to human dosing remains unestablished. No large-scale randomized controlled trials in humans have been completed, and efficacy data in humans is essentially absent.

Nutritional Profile

Phloretin is a dihydrochalcone flavonoid compound (molecular formula C15H14O5, molecular weight 274.27 g/mol), not a whole food ingredient, so conventional macronutrient/micronutrient framing does not apply. Bioactive compound profile: Phloretin is the aglycone form of phlorizin (phloretin-2'-O-glucoside), formed via hydrolysis of phlorizin by gut microbiota or intestinal enzymes. It is found primarily in apple skin, apple juice, and apple-derived products at concentrations typically ranging from 0.1–5 mg/100g fresh weight in apple peel, with trace amounts in pear and strawberry. As a pure compound, it contains no protein, fat, carbohydrate, fiber, vitamins, or minerals. Structurally, it possesses a resorcinol ring and a phloroglucinol ring connected by a three-carbon chain with two carbonyl groups, contributing to its antioxidant capacity (DPPH radical scavenging IC50 reported at approximately 15–30 µM in vitro). Bioavailability: oral bioavailability is limited due to poor aqueous solubility (~0.1 mg/mL at physiological pH); intestinal absorption occurs via passive diffusion and SGLT1 inhibition (phloretin is a known SGLT1/GLUT2 transporter inhibitor). Plasma concentrations after dietary intake from whole apples are typically in the nanomolar range (1–50 nM). First-pass metabolism converts phloretin to phloretic acid and other phenolic metabolites. Stability is pH- and light-sensitive; degrades under alkaline conditions.

Preparation & Dosage

No clinically studied dosage ranges are available. Forms, standardization details, and safe dosing parameters have not been established in human research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Quercetin, chlorogenic acid, catechins, procyanidins, cisplatin (in vitro only)

Safety & Interactions

Phloretin has not been evaluated in formal human safety trials, and no established tolerable upper intake level or therapeutic dose range exists for supplemental use. Because phloretin inhibits GLUT2 glucose transporters, it may theoretically potentiate blood glucose-lowering effects of antidiabetic medications such as metformin or insulin, warranting caution in diabetic patients. Its potential to enhance cisplatin cytotoxicity suggests a possible interaction with chemotherapy agents, and use alongside oncology treatments should only occur under medical supervision. Safety during pregnancy and lactation is unknown due to absence of relevant human data, and supplemental use should be avoided in these populations.